Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years

Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI

NCT03301155 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza Symptoms

NCT06774859 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms

NCT03629184 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children

NCT07171099 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.

NCT03191097 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection

NCT04244084 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat

NCT06244615 ·Status: COMPLETED ·Phase: NA

Treatment of Influenza and ARVI in Children by Kagocel ®

NCT04651491 ·Status: COMPLETED

Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections

NCT06315400 ·Status: RECRUITING ·Phase: PHASE4

Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

NCT06379542 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy of ADC189 in Children 2-11 Years Old With Influenza

NCT06507813 ·Status: COMPLETED ·Phase: PHASE3

Trial of the Efficacy and Safety of Use of Drug Product Reamberin® for Pathogenetic Therapy of Viral Enteric Infection in Children Aged 1-6 Years Old

NCT07066540 ·Status: RECRUITING

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.

NCT03206346 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial Investigating the Short-term Relief of Symptoms of Acute Pharyngitis by Treatment With Three Different Doses of MYRAMISTIN™ Oromucosal Spray

NCT04470089 ·Status: TERMINATED ·Phase: PHASE2

Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

NCT04250311 ·Status: SUSPENDED ·Phase: PHASE3

Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children

NCT01843842 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Drug-Drug Interaction Between VX-787 and Oseltamivir

NCT02262715 ·Status: COMPLETED ·Phase: PHASE1

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

NCT06094010 ·Status: RECRUITING ·Phase: PHASE3

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

NCT04475107 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Clinical Efficacy and Safety of Recombinant Human Interferon ω Spray in Treatment of Viral Upper Respiratory Tract Infection in Children

NCT05859984 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

NCT03039621 ·Status: COMPLETED ·Phase: PHASE4

Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults

NCT02008344 ·Status: COMPLETED ·Phase: PHASE3

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

NCT04489381 ·Status: TERMINATED ·Phase: PHASE3

Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza

NCT01068912 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI

NCT03830905 ·Status: COMPLETED ·Phase: PHASE2